| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |